Top

Published in:

Open Access 01-12-2009 | Research article

The INSIG2 rs7566605 genetic variant does not play a major role in obesity in a sample of 24,722 individuals from four cohorts

Authors: Jan Bressler, Myriam Fornage, Craig L Hanis, Wen Hong Linda Kao, Cora E Lewis, Ruth McPherson, Robert Dent, Thomas H Mosley, Len A Pennacchio, Eric Boerwinkle

Published in: BMC Medical Genetics | Issue 1/2009

Abstract

Background

In a genome-wide association study performed in the Framingham Offspring Cohort, individuals homozygous for the rs7566605 C allele located upstream of insulin-induced gene 2 (INSIG2) were reported to incur an increased risk of obesity. This finding was later replicated in four out of five populations examined. The goal of the study reported here was to assess the role of the INSIG2 single nucleotide polymorphism (SNP) in susceptibility to obesity in the prospective longitudinal Atherosclerosis Risk in Communities (ARIC) study (n = 14,566) and in three other cohorts: the Coronary Artery Risk Development in Young Adults (CARDIA) study (n = 3,888), the Genetic Epidemiology Network of Arteriopathy (GENOA) study (n = 4,766), and extremely obese and lean individuals ascertained at the University of Ottawa (n = 1,502). The combined study sample is comprised of 24,722 white, African-American, and Mexican-American participants.

Methods

Differences in mean body mass index (BMI) and other anthropometric measures including weight, waist circumference, and waist-to-hip ratio were assessed by a general linear model in individuals categorized by INSIG2 rs7566605 genotype. Multivariable logistic regression was used to predict the risk of obesity (BMI ≥ 30 kg/m²).

Results

There was no discernable variation in the frequencies of the three INSIG2 SNP genotypes observed between white, Hispanic, and African-American obese individuals and non-obese study subjects. When the relationship between rs7566605 and BMI considered either as a categorical variable or a continuous variable was examined, no significant association with obesity was found for participants in any of the four study populations or in a combined analysis (p = 0.38) under a recessive genetic model. There was also no association between the INSIG2 polymorphism and the obesity-related quantitative traits except for a reduced waist-to-hip ratio in white ARIC study participants homozygous for the C allele, and an increased waist-to-hip ratio in African-Americans in the ARIC cohort with the same genotype (p = 0.04 and p = 0.01, respectively). An association with waist-to-hip ratio was not seen when the combined study sample was analyzed (p = 0.74).

Conclusion

These results suggest that the INSIG2 rs7566605 variant does not play a major role in determining obesity risk in a racially and ethnically diverse sample of 24,722 individuals from four cohorts.

Must A, Spadano J, Coakley EH, Field AE, Colditz G, Dietz WH: The disease burden associated with overweight and obesity. Jama. 1999, 282: 1523-1529. 10.1001/jama.282.16.1523.CrossRefPubMed

Harris T, Cook EF, Garrison R, Higgins M, Kannel W, Goldman L: Body mass index and mortality among nonsmoking older persons. The Framingham Heart Study. Jama. 1988, 259: 1520-1524. 10.1001/jama.259.10.1520.CrossRefPubMed

Stunkard AJ, Foch TT, Hrubec Z: A twin study of human obesity. Jama. 1986, 256: 51-54. 10.1001/jama.256.1.51.CrossRefPubMed

Stunkard AJ, Harris JR, Pedersen NL, McClearn GE: The body-mass index of twins who have been reared apart. N Engl J Med. 1990, 322: 1483-1487.CrossRefPubMed

Stunkard AJ, Sorensen TI, Hanis C, Teasdale TW, Chakraborty R, Schull WJ, Schulsinger F: An adoption study of human obesity. N Engl J Med. 1986, 314: 193-198.CrossRefPubMed

Friedman JM: Modern science versus the stigma of obesity. Nat Med. 2004, 10: 563-569. 10.1038/nm0604-563.CrossRefPubMed

Flegal KM, Carroll MD, Ogden CL, Johnson CL: Prevalence and trends in obesity among US adults, 1999–2000. Jama. 2002, 288: 1723-1727. 10.1001/jama.288.14.1723.CrossRefPubMed

Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM: Prevalence of overweight and obesity in the United States, 1999–2004. Jama. 2006, 295: 1549-1555. 10.1001/jama.295.13.1549.CrossRefPubMed

A haplotype map of the human genome. Nature. 2005, 437: 1299-1320. 10.1038/nature04226.

10.

Frayling TM, Timpson NJ, Weedon MN, Zeggini E, Freathy RM, Lindgren CM, Perry JR, Elliott KS, Lango H, Rayner NW, et al: A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science. 2007, 316: 889-894. 10.1126/science.1141634.CrossRefPubMedPubMedCentral

11.

Dina C, Meyre D, Gallina S, Durand E, Korner A, Jacobson P, Carlsson LM, Kiess W, Vatin V, Lecoeur C, et al: Variation in FTO contributes to childhood obesity and severe adult obesity. Nat Genet. 2007, 39: 724-726. 10.1038/ng2048.CrossRefPubMed

12.

Scuteri A, Sanna S, Chen WM, Uda M, Albai G, Strait J, Najjar S, Nagaraja R, Orru M, Usala G, et al: Genome-wide association scan shows genetic variants in the FTO gene are associated with obesity-related traits. PLoS Genet. 2007, 3: e115-10.1371/journal.pgen.0030115.CrossRefPubMedPubMedCentral

13.

Loos RJ, Lindgren CM, Li S, Wheeler E, Zhao JH, Prokopenko I, Inouye M, Freathy RM, Attwood AP, Beckmann JS, et al: Common variants near MC4R are associated with fat mass, weight and risk of obesity. Nat Genet. 2008, 40: 768-775. 10.1038/ng.140.CrossRefPubMedPubMedCentral

14.

Chambers JC, Elliott P, Zabaneh D, Zhang W, Li Y, Froguel P, Balding D, Scott J, Kooner JS: Common genetic variation near MC4R is associated with waist circumference and insulin resistance. Nat Genet. 2008, 40: 716-718. 10.1038/ng.156.CrossRefPubMed

15.

Liu YJ, Liu XG, Wang L, Dina C, Yan H, Liu JF, Levy S, Papasian CJ, Drees BM, Hamilton JJ, et al: Genome-wide association scans identified CTNNBL1 as a novel gene for obesity. Hum Mol Genet. 2008, 17: 1803-1813. 10.1093/hmg/ddn072.CrossRefPubMedPubMedCentral

16.

Thorleifsson G, Walters GB, Gudbjartsson DF, Steinthorsdottir V, Sulem P, Helgadottir A, Styrkarsdottir U, Gretarsdottir S, Thorlacius S, Jonsdottir I, et al: Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity. Nat Genet. 2009, 41: 18-24. 10.1038/ng.274.CrossRefPubMed

17.

Willer CJ, Speliotes EK, Loos RJ, Li S, Lindgren CM, Heid IM, Berndt SI, Elliott AL, Jackson AU, Lamina C, et al: Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nat Genet. 2009, 41: 25-34. 10.1038/ng.287.CrossRefPubMed

18.

Meyre D, Delplanque J, Chevre JC, Lecoeur C, Lobbens S, Gallina S, Durand E, Vatin V, Degraeve F, Proenca C, et al: Genome-wide association study for early-onset and morbid adult obesity identifies three new risk loci in European populations. Nat Genet. 2009, 41: 157-159. 10.1038/ng.301.CrossRefPubMed

19.

Herbert A, Gerry NP, McQueen MB, Heid IM, Pfeufer A, Illig T, Wichmann HE, Meitinger T, Hunter D, Hu FB, et al: A common genetic variant is associated with adult and childhood obesity. Science. 2006, 312: 279-283. 10.1126/science.1124779.CrossRefPubMed

20.

Lyon HN, Emilsson V, Hinney A, Heid IM, Lasky-Su J, Zhu X, Thorleifsson G, Gunnarsdottir S, Walters GB, Thorsteinsdottir U, et al: The association of a SNP upstream of INSIG2 with body mass index is reproduced in several but not all cohorts. PLoS Genet. 2007, 3: e61-10.1371/journal.pgen.0030061.CrossRefPubMedPubMedCentral

21.

The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. Am J Epidemiol. 1989, 129: 687-702.

22.

Hughes GH, Cutter G, Donahue R, Friedman GD, Hulley S, Hunkeler E, Jacobs DR, Liu K, Orden S, Pirie P, et al: Recruitment in the Coronary Artery Disease Risk Development in Young Adults (Cardia) Study. Control Clin Trials. 1987, 8: 68S-73S. 10.1016/0197-2456(87)90008-0.CrossRefPubMed

23.

Friedman GD, Cutter GR, Donahue RP, Hughes GH, Hulley SB, Jacobs DR, Liu K, Savage PJ: CARDIA: study design, recruitment, and some characteristics of the examined subjects. J Clin Epidemiol. 1988, 41: 1105-1116. 10.1016/0895-4356(88)90080-7.CrossRefPubMed

24.

Multi-center genetic study of hypertension: The Family Blood Pressure Program (FBPP). Hypertension. 2002, 39: 3-9. 10.1161/hy1201.100415.

25.

Ahituv N, Kavaslar N, Schackwitz W, Ustaszewska A, Martin J, Hebert S, Doelle H, Ersoy B, Kryukov G, Schmidt S, et al: Medical sequencing at the extremes of human body mass. Am J Hum Genet. 2007, 80: 779-791. 10.1086/513471.CrossRefPubMedPubMedCentral

26.

Brown AJ, Sun L, Feramisco JD, Brown MS, Goldstein JL: Cholesterol addition to ER membranes alters conformation of SCAP, the SREBP escort protein that regulates cholesterol metabolism. Mol Cell. 2002, 10: 237-245. 10.1016/S1097-2765(02)00591-9.CrossRefPubMed

27.

Brown MS, Goldstein JL: A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood. Proc Natl Acad Sci USA. 1999, 96: 11041-11048. 10.1073/pnas.96.20.11041.CrossRefPubMedPubMedCentral

28.

Edwards PA, Tabor D, Kast HR, Venkateswaran A: Regulation of gene expression by SREBP and SCAP. Biochim Biophys Acta. 2000, 1529: 103-113.CrossRefPubMed

29.

Goldstein JL, Rawson RB, Brown MS: Mutant mammalian cells as tools to delineate the sterol regulatory element-binding protein pathway for feedback regulation of lipid synthesis. Arch Biochem Biophys. 2002, 397: 139-148. 10.1006/abbi.2001.2615.CrossRefPubMed

30.

Horton JD, Goldstein JL, Brown MS: SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest. 2002, 109: 1125-1131.CrossRefPubMedPubMedCentral

31.

Yabe D, Brown MS, Goldstein JL: Insig-2, a second endoplasmic reticulum protein that binds SCAP and blocks export of sterol regulatory element-binding proteins. Proc Natl Acad Sci USA. 2002, 99: 12753-12758. 10.1073/pnas.162488899.CrossRefPubMedPubMedCentral

32.

Goldstein JL, Brown MS: Regulation of the mevalonate pathway. Nature. 1990, 343: 425-430. 10.1038/343425a0.CrossRefPubMed

33.

Yang T, Espenshade PJ, Wright ME, Yabe D, Gong Y, Aebersold R, Goldstein JL, Brown MS: Crucial step in cholesterol homeostasis: sterols promote binding of SCAP to INSIG-1, a membrane protein that facilitates retention of SREBPs in ER. Cell. 2002, 110: 489-500. 10.1016/S0092-8674(02)00872-3.CrossRefPubMed

34.

Ravid T, Doolman R, Avner R, Harats D, Roitelman J: The ubiquitin-proteasome pathway mediates the regulated degradation of mammalian 3-hydroxy-3-methylglutaryl-coenzyme A reductase. J Biol Chem. 2000, 275: 35840-35847. 10.1074/jbc.M004793200.CrossRefPubMed

35.

Sever N, Song BL, Yabe D, Goldstein JL, Brown MS, DeBose-Boyd RA: Insig-dependent ubiquitination and degradation of mammalian 3-hydroxy-3-methylglutaryl-CoA reductase stimulated by sterols and geranylgeraniol. J Biol Chem. 2003, 278: 52479-52490. 10.1074/jbc.M310053200.CrossRefPubMed

36.

Takaishi K, Duplomb L, Wang MY, Li J, Unger RH: Hepatic insig-1 or -2 overexpression reduces lipogenesis in obese Zucker diabetic fatty rats and in fasted/refed normal rats. Proc Natl Acad Sci USA. 2004, 101: 7106-7111. 10.1073/pnas.0401715101.CrossRefPubMedPubMedCentral

37.

Cutter GR, Burke GL, Dyer AR, Friedman GD, Hilner JE, Hughes GH, Hulley SB, Jacobs DR, Liu K, Manolio TA, et al: Cardiovascular risk factors in young adults. The CARDIA baseline monograph. Control Clin Trials. 1991, 12: 1S-77S. 10.1016/0197-2456(91)90002-4.CrossRefPubMed

38.

Daniels PR, Kardia SL, Hanis CL, Brown CA, Hutchinson R, Boerwinkle E, Turner ST: Familial aggregation of hypertension treatment and control in the Genetic Epidemiology Network of Arteriopathy (GENOA) study. Am J Med. 2004, 116: 676-681. 10.1016/j.amjmed.2003.12.032.CrossRefPubMed

39.

WHO: Obesity: preventing and managing the global epidemic. Report of a WHO consultation. WHO Technical Report Series. Geneva. 2000, 894:

40.

Hotta K, Nakamura M, Nakata Y, Matsuo T, Kamohara S, Kotani K, Komatsu R, Itoh N, Mineo I, Wada J, et al: INSIG2 gene rs7566605 polymorphism is associated with severe obesity in Japanese. J Hum Genet. 2008, 53: 857-862. 10.1007/s10038-008-0317-8.CrossRefPubMedPubMedCentral

41.

Zhang J, Lin R, Wang F, Lu M, Lin RY, Wang SZ, Wen H, Jin L, Wang XF: A common polymorphism is associated with body mass index in Uyghur population. Diabetes Res Clin Pract. 2008, 81: e11-13. 10.1016/j.diabres.2008.03.022.CrossRefPubMed

42.

Yang L, Wu Y, Li H, Yu Z, Li X, Liu Y, Lin X, Chen Y: Potential association of INSIG2 rs7566605 polymorphism with body weight in a Chinese subpopulation. Eur J Hum Genet. 2008, 16: 759-761. 10.1038/ejhg.2008.8.CrossRefPubMed

43.

Orkunoglu-Suer FE, Gordish-Dressman H, Clarkson PM, Thompson PD, Angelopoulos TJ, Gordon PM, Moyna NM, Pescatello LS, Visich PS, Zoeller RF, et al: INSIG2 gene polymorphism is associated with increased subcutaneous fat in women and poor response to resistance training in men. BMC Med Genet. 2008, 9: 117-10.1186/1471-2350-9-117.CrossRefPubMedPubMedCentral

44.

Hall DH, Rahman T, Avery PJ, Keavney B: INSIG-2 promoter polymorphism and obesity related phenotypes: association study in 1428 members of 248 families. BMC Med Genet. 2006, 7: 83-10.1186/1471-2350-7-83.CrossRefPubMedPubMedCentral

45.

Dina C, Meyre D, Samson C, Tichet J, Marre M, Jouret B, Charles MA, Balkau B, Froguel P: Comment on "A common genetic variant is associated with adult and childhood obesity". Science. 2007, 315: 187-10.1126/science.1129402.CrossRefPubMed

46.

Loos RJ, Barroso I, O'Rahilly S, Wareham NJ: Comment on "A common genetic variant is associated with adult and childhood obesity". Science. 2007, 315: 187-10.1126/science.1130012.CrossRefPubMedPubMedCentral

47.

Rosskopf D, Bornhorst A, Rimmbach C, Schwahn C, Kayser A, Kruger A, Tessmann G, Geissler I, Kroemer HK, Volzke H: Comment on "A common genetic variant is associated with adult and childhood obesity". Science. 2007, 315: 187-10.1126/science.1130571. author reply 187CrossRefPubMed

48.

Kumar J, Sunkishala RR, Karthikeyan G, Sengupta S: The common genetic variant upstream of INSIG2 gene is not associated with obesity in Indian population. Clin Genet. 2007, 71: 415-418. 10.1111/j.1399-0004.2007.00795.x.CrossRefPubMed

49.

Smith AJ, Cooper JA, Li LK, Humphries SE: INSIG2 gene polymorphism is not associated with obesity in Caucasian, Afro-Caribbean and Indian subjects. Int J Obes (Lond). 2007, 31: 1753-1755. 10.1038/sj.ijo.0803645.CrossRef

50.

Kuzuya M, Ando F, Iguchi A, Shimokata H: No association between rs7566605 variant and being overweight in Japanese. Obesity (Silver Spring). 2007, 15: 2531-2534. 10.1038/oby.2007.301.CrossRef

51.

Tabara Y, Kawamoto R, Osawa H, Nakura J, Makino H, Miki T, Kohara K: No association between INSIG2 Gene rs7566605 polymorphism and being overweight in Japanese population. Obesity (Silver Spring). 2008, 16: 211-215. 10.1038/oby.2007.25.CrossRef

52.

Andreasen CH, Mogensen MS, Borch-Johnsen K, Sandbaek A, Lauritzen T, Sorensen TI, Hansen L, Almind K, Jorgensen T, Pedersen O, Hansen T: Non-replication of genome-wide based associations between common variants in INSIG2 and PFKP and obesity in studies of 18,014 Danes. PLoS ONE. 2008, 3: e2872-10.1371/journal.pone.0002872.CrossRefPubMedPubMedCentral

53.

Boes E, Kollerits B, Heid IM, Hunt SC, Pichler M, Paulweber B, Coassin S, Adams TD, Hopkins PN, Lingenhel A, et al: INSIG2 polymorphism is neither associated with BMI nor with phenotypes of lipoprotein metabolism. Obesity (Silver Spring). 2008, 16: 827-833. 10.1038/oby.2007.132.CrossRef

54.

Oki K, Yamane K, Kamei N, Asao T, Awaya T, Kohno N: The single nucleotide polymorphism upstream of insulin-induced gene 2 (INSIG2) is associated with the prevalence of hypercholesterolaemia, but not with obesity, in Japanese American women. Br J Nutr. 2009, 101: 322-327. 10.1017/S0007114508006557.CrossRefPubMed

55.

Wiedmann S, Neureuther K, Stark K, Reinhard W, Kallmunzer B, Baessler A, Fischer M, Linsel-Nitschke P, Erdmann J, Schunkert H, Hengstenberg C: Lack of Association Between a Common Polymorphism Near the INSIG2 Gene and BMI, Myocardial Infarction, and Cardiovascular Risk Factors. Obesity (Silver Spring). 2009

56.

Vimaleswaran KS, Franks PW, Brage S, Sardinha LB, Andersen LB, Wareham NJ, Ekelund U, Loos RJ: Absence of Association Between the INSIG2 Gene Polymorphism (rs7566605) and Obesity in the European Youth Heart Study (EYHS). Obesity (Silver Spring). 2009

57.

Yabe D, Komuro R, Liang G, Goldstein JL, Brown MS: Liver-specific mRNA for Insig-2 down-regulated by insulin: implications for fatty acid synthesis. Proc Natl Acad Sci USA. 2003, 100: 3155-3160. 10.1073/pnas.0130116100.CrossRefPubMedPubMedCentral

58.

Samet JM, Coultas DB, Howard CA, Skipper BJ, Hanis CL: Diabetes, gallbladder disease, obesity, and hypertension among Hispanics in New Mexico. Am J Epidemiol. 1988, 128: 1302-1311.PubMed

59.

Yusuf S, Hawken S, Ounpuu S, Bautista L, Franzosi MG, Commerford P, Lang CC, Rumboldt Z, Onen CL, Lisheng L, et al: Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet. 2005, 366: 1640-1649. 10.1016/S0140-6736(05)67663-5.CrossRefPubMed

60.

Winter Y, Rohrmann S, Linseisen J, Lanczik O, Ringleb PA, Hebebrand J, Back T: Contribution of obesity and abdominal fat mass to risk of stroke and transient ischemic attacks. Stroke. 2008, 39: 3145-3151. 10.1161/STROKEAHA.108.523001.CrossRefPubMed

The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2350/10/56/prepub

Title: The INSIG2 rs7566605 genetic variant does not play a major role in obesity in a sample of 24,722 individuals from four cohorts
Authors: Jan Bressler
Myriam Fornage
Craig L Hanis
Wen Hong Linda Kao
Cora E Lewis
Ruth McPherson
Robert Dent
Thomas H Mosley
Len A Pennacchio
Eric Boerwinkle
Publication date: 01-12-2009
Publisher: BioMed Central
Published in: BMC Medical Genetics / Issue 1/2009
Electronic ISSN: 1471-2350
DOI: https://doi.org/10.1186/1471-2350-10-56

Keynote webinar | Spotlight on medication adherence

Springer Medicine

The INSIG2 rs7566605 genetic variant does not play a major role in obesity in a sample of 24,722 individuals from four cohorts

Abstract

Background

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2009

Genome screen in familial intracranial aneurysm

The role of CACNA1Sin predisposition to malignant hyperthermia

Variation in the UCP2 and UCP3genes associates with abdominal obesity and serum lipids: The Finnish Diabetes Prevention Study

DNA instability in replicating Huntington's disease lymphoblasts

Single nucleotide polymorphisms in obesity-related genes and all-cause and cause-specific mortality: a prospective cohort study

Association of a de novo16q copy number variant with a phenotype that overlaps with Lenz microphthalmia and Townes-Brocks syndromes